Recombinant Expression and Stapling of a Novel Long-Acting GLP-1R Peptide Agonist

Owing to their pleiotropic metabolic benefits, glucagon-like peptide-1 receptor (GLP-1R) agonists have been successfully utilized for treating metabolic diseases, such as type 2 diabetes and obesity. As part of our efforts in developing long-acting peptide therapeutics, we have previously reported a...

Descripción completa

Detalles Bibliográficos
Autores principales: Lear, Sam, Seo, Hyosuk, Lee, Candy, Lei, Lei, Amso, Zaid, Huang, David, Zou, Huafei, Zhou, Zhihong, Nguyen-Tran, Vân T. B., Shen, Weijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7321126/
https://www.ncbi.nlm.nih.gov/pubmed/32481528
http://dx.doi.org/10.3390/molecules25112508

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7321126/
https://www.ncbi.nlm.nih.gov/pubmed/32481528
http://dx.doi.org/10.3390/molecules25112508

Ejemplares similares